Tamoxifen Citrate (54965-24-1) Manufacturer - Buyaas

Tamoxifen Citrate (54965-24-1)

November 8, 2018

Tamoxifen Citrate is the citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition,


Status: In Mass Production
Unit: 25kg/Drum
Capacity: 1610kg/month

Tamoxifen Citrate (54965-24-1) video

 

Tamoxifen Citrate (54965-24-1) Description

Tamoxifen Citrate is the citrate salt of an antineoplastic nonsteroidal selective estrogen receptor modulator (SERM). Tamoxifen competitively inhibits the binding of estradiol to estrogen receptors, thereby preventing the receptor from binding to the estrogen-response element on DNA. The result is a reduction in DNA synthesis and cellular response to estrogen. In addition, tamoxifen up-regulates the production of transforming growth factor B (TGFb), a factor that inhibits tumor cell growth, and down-regulates insulin-like growth factor 1 (IGF-1), a factor that stimulates breast cancer cell growth. Tamoxifen also down-regulates protein kinase C (PKC) expression in a dose-dependant manner, inhibiting signal transduction and producing an antiproliferative effect in tumors such as malignant glioma and other cancers that overexpress PKC.

Tamoxifen citrate use to the treatment and prevention of estrogen receptor positive breast cancer. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the endometrium.

 

Tamoxifen Citrate (54965-24-1) Specifications

Product Name Tamoxifen Citrate
Chemical Name Istubal; Tamoxifen,
Brand Name Nolvadex
Drug Class selective estrogen receptor modulator (SERM)
CAS Number 54965-24-1
InChIKey FQZYTYWMLGAPFJ-OQKDUQJOSA-N
Molecular Formula C32H37NO8
Molecular Weight 563.647 g/mol
Monoisotopic Mass 563.252 g/mol
Melting Point  97 °C
Freezing Point No data available
Biological Half-Life The decline in tamoxifen plasma concentrations is biphasic with a terminal elimination half-life of approximately 5 to 7 days. The estimated half-life of N-desmethyl tamoxifen is 14 days.
Color White or off-white powder
Solubility  water solubility 0.000167 mg/mL at 25 °C
Storage Temperature  2-8°C
Application use to the treatment and prevention of estrogen receptor positive breast cancer.

 


=

Reviews

There are no reviews yet.

Be the first to review “Tamoxifen Citrate (54965-24-1)”

Your email address will not be published.